Business News

AstraZeneca vaccine details published in Lancet, but data suggests need for more trials – Washington Post

The researchers said they are now submitting their data to regulators for approval to deploy the vaccine in mass immunization campaigns in Britain, Brazil, India and countries in Europe, among other places.
The AstraZeneca vaccine, if approved, will compete with one produced by the American pharmaceutical giant Pfizer and its German partner BioNTech, which is reported to be 95 percent effective.
The Pfizer vaccine was approved for emergency use in Britain and the first injections in a massive campaign…

Click here to view the original article.

Related Posts

You might also like ...